HR | Ticker Profile - Titan Protect

Healthcare Realty Trust Incorporated

Real Estate · REIT - Healthcare Facilities · NYQ

$19.65

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 85.7%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$7.1B

Total market value of the company

Trailing P/E

N/A

Forward P/E

-202.00

Based on estimated future earnings — lower means cheaper

Rev Growth

-6.5%

Year-over-year revenue change

Profit Margin

-17.3%

How much profit the company keeps from each dollar of revenue

ROE

-4.2%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$21.00

+7% from current price — median analyst estimate

Recommendation

HOLD

Consensus view from 11 analysts covering this stock

About Healthcare Realty Trust Incorporated

Healthcare Realty Trust Incorporated is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As of September 30, 2025, the Company was invested in 579 real estate properties in 28 states totaling 33.6 million square feet and had an enterprise value of approximately 11.1 billion dollars, defined as equity market capitalization plus the principal amount of debt less cash. Healthcare Realty Trust Incorporated was incorporated in 1992 and is based in Nashville, United States.

https://www.healthcarerealty.com

Country: United States Employees: 539 Industry: REIT - Healthcare Facilities

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

ACCUMULATION

Smart money appears to be building positions quietly

Sharpe Ratio

0.992

Good returns relative to risk taken

Kelly Fraction

0.0455

Modest edge detected — smaller position warranted

Calmar Ratio

1.036

Returns exceed worst-case losses — strong risk profile

Annual Return

21.3%

Historical annualised return based on price data

Max Drawdown

-20.5%

Largest peak-to-trough decline — the worst it has been

HMM State

BULL

Statistical model sees bullish momentum

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.82

Less volatile than the market — more defensive

52W High

$20.61

5% below the year high

52W Low

$14.09

39% above the year low

Avg Volume

3,739,734

Average daily shares traded — higher means easier to buy and sell

Short Ratio

3.4

Days it would take all short sellers to cover — higher means more crowded

Short % Float

8.3%

Moderate short interest

Div Yield

475.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$-0.58

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

96.51

Heavy leverage — higher financial risk if revenues decline

Current Ratio

0.32

Below 1 means short-term obligations exceed liquid assets — risk flag

Quick Ratio

0.04

Like current ratio but excludes inventory — stricter test

Gross Margin

62.0%

Revenue left after cost of goods — higher means pricing power

Operating Margin

11.5%

Profit from core operations before interest and tax

Free Cash Flow

$144M

Positive — the business generates more cash than it spends

Revenue (TTM)

$1.2B

Total revenue over the last 12 months

Net Income

$-203,810,000

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$22.00

Target Median

$21.00

Target Low

$18.00

Political Trading Activity

Congressional trading disclosures involving this instrument

Date	Politician	Party	Type	Amount
9 Apr2026	Josh Gottheimer	Democrat	sell	15K–50K
30 Apr2026	Dave McCormick	Republican	sell	100K–250K
2026-05-08	Bill Keating	Democrat	Purchase	1K–15K
2026-04-13	Ro Khanna	Democrat	Sale	1K–15K
2026-04-09	Josh Gottheimer	Democrat	Sale	15K–50K

Source: Congressional disclosure filings. View all political trades at

Insider Intelligence

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go